Copertina

Optic pathway gliomas in children: Clinical characteristics, treatment, and outcome of 95 patients in a single center over a 31‐year period. Can we avoid radiotherapy?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Rejin Kebudi, Ulku Miray Yildirim, Ayça İribaş, Samuray Tuncer
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Staining the Invisible: Immunohistochemistry for Early Detection of Mismatch Repair Deficiency in Pediatric High‐Grade Brain Tumors
di: Ulku Miray Yildirim, et al.
Pubblicazione: (2025)

Keeping Hope for Dying Children and Their Families: The Experiences of Physicians and Nurses in Pediatric Oncology
di: Hülya Dalkılıç Bingöl, et al.
Pubblicazione: (2025)

Re‐irradiation in Children With Recurrent Medulloblastoma
di: Ayça İribaş Çelik, et al.
Pubblicazione: (2025)

Cabozantinib in children with recurrent diffuse gliomas
di: Ludmila Papusha, et al.
Pubblicazione: (2024)

Long‐term outcomes following proton therapy for pediatric spinal low‐grade glioma
di: Ryan J. Brisson, et al.
Pubblicazione: (2024)

Safety and tolerability of intravenous aprepitant and fosaprepitant in children with cancer: A retrospective, single‐center review
di: Srivarshini Kanukollu, et al.
Pubblicazione: (2024)

Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome
di: Carlien A. Bennebroek, et al.
Pubblicazione: (2024)

Management of neonatal and infant aortic thrombosis: A single‐center case series
di: Ajibike Lapite, et al.
Pubblicazione: (2024)

Growing teratoma syndrome in children and adolescents: Prevalence and surgical outcome
di: Federico Beati, et al.
Pubblicazione: (2024)

Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey
di: Elisabeth T. Tracy, et al.
Pubblicazione: (2024)

Real‐world experience of direct oral anticoagulant use in a single pediatric center
di: Gianna G. Valenti, et al.
Pubblicazione: (2024)

The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single‐center experience
di: Andres F. Espinoza, et al.
Pubblicazione: (2024)

Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single‐center retrospective study
di: Sean Schoeman, et al.
Pubblicazione: (2024)

Management of acute appendicitis in pediatric patients with acute leukemia: Insights from a single‐center study
di: Hila Rosenfeld Keidar, et al.
Pubblicazione: (2024)

Correction to “Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience.”
Pubblicazione: (2024)

Parenteral iron therapy in children with iron deficiency anemia: A single‐institution experience
di: Jelena Roganovic
Pubblicazione: (2024)

Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
di: Wei‐Zhen Tang, et al.
Pubblicazione: (2024)

Upfront immunotherapy for synchronous high‐grade glioma and B‐lymphoma in a pediatric patient with CMMRD syndrome
di: Thérèse De Vanssay, et al.
Pubblicazione: (2024)

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
di: Nisreen Amayiri, et al.
Pubblicazione: (2024)

Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
di: Ajibike Lapite, et al.
Pubblicazione: (2024)

Invasive fungal disease in children with solid tumors: An Australian multicenter 10‐year review
di: Neha Jain, et al.
Pubblicazione: (2024)

The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer
di: Philip J. Lupo, et al.
Pubblicazione: (2024)

Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
di: Jennifer Longoria, et al.
Pubblicazione: (2024)

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes
di: Cristina Larrosa, et al.
Pubblicazione: (2024)

Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan
di: Reema Kashif, et al.
Pubblicazione: (2024)

Ifosfamide‐Related Optic Nerve Toxicity: Case Description and Review of the Literature
di: Nalla Silva Baticam, et al.
Pubblicazione: (2025)

Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation
di: Hilde Hylland Uhlving, et al.
Pubblicazione: (2024)

Risk of transfusion‐related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center
di: Shelby Winzent‐Oonk, et al.
Pubblicazione: (2024)

Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord‐stromal tumors. Results of the TGM13 National Registry
di: Clemence Fuentes, et al.
Pubblicazione: (2024)

Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?
di: Qingtian Liang, et al.
Pubblicazione: (2025)

Optic Nerve Sheath Meningiomas in Children: Diagnostic Challenges Based on a Case Series
di: Deysha Ratnasingham, et al.
Pubblicazione: (2025)

Adolescent with primary cutaneous follicle center lymphoma treated with rituximab
di: Kaitlin J. Devine, et al.
Pubblicazione: (2024)

Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980–2019: An analysis of 40 years based on data from the German Childhood Cancer Registry
di: Maike Wellbrock, et al.
Pubblicazione: (2024)

Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes
di: Sameer Farouk Sait, et al.
Pubblicazione: (2024)

Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors
di: Aviv Sever, et al.
Pubblicazione: (2025)

Risk factors for parental divorce in children with cancer
di: Hüseyin Çaksen
Pubblicazione: (2024)

Congenital hepatoblastoma: Expanding knowledge, improving outcomes
di: Francesca Gigola, et al.
Pubblicazione: (2024)

Treatment outcomes in retinoblastoma and the effect of tumor topography
di: Wajiha J. Kheir, et al.
Pubblicazione: (2024)

Reducing ambulatory central line‐associated bloodstream infections: A family‐centered approach
di: Chris I. Wong, et al.
Pubblicazione: (2024)

Spiritual needs of children and adolescents with cancer at the end of life
di: Hüseyin Çaksen
Pubblicazione: (2024)